SCHEMBL12848657

SCHEMBL12848657

CCC(=O)c1cc2cc(OCCN(C)C)c(OC)cc2o1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.43
NOS3 P29474 2/20 0.42
NOS1 P29475 2/20 0.42
THRA P10827 1/20 0.42
THRB P10828 1/20 0.42
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HRH3 Q9Y5N1 2/20 0.40
DRD2 P14416 1/20 0.40
DRD3 P35462 1/20 0.40
KDM4E B2RXH2 1/20 0.39
HTR7 P34969 1/20 0.39
MCHR1 Q99705 1/20 0.39
MAPK1 P28482 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PTPN1 P18031 1/20 0.38
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
OPRM1 P35372 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15623107 0.89 CYP2D6 (0.44) CYP2D6NOS3NOS1THRATHRB
SCHEMBL12795523 0.85 CYP2D6 (0.41) CYP2D6NOS3NOS1ALDH1A1HRH3
SCHEMBL12848549 0.79 ALDH1A1 (0.53) CYP2D6THRAALDH1A1KDM4EMAPK1
SCHEMBL12848576 0.76 FLT3 (0.50) NOS3NOS1THRATHRBMTNR1A
SCHEMBL31377048 0.75 MCL1 (0.68) ALDH1A1KDM4EHSD17B10
SCHEMBL15623100 0.74 CA9 (0.50) CYP2D6MTNR1AMTNR1BALDH1A1HRH3
SCHEMBL12795516 0.71 CA9 (0.46) CYP2D6ALDH1A1HRH3DRD3KDM4E
SCHEMBL9208712 0.70 RAB9A (0.45) KDM4EHSD17B10BCHEACHEOPRM1
SCHEMBL4766674 0.70 PIM1 (0.55) THRATHRBALDH1A1KDM4EHSD17B10
SCHEMBL16492619 0.70 LMNA (0.57) ALDH1A1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065767-A1 Substituted CC-1065 Analogs and Their Conjugates SYNTARGA B.V. (NL) 2011-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065767-A1 Substituted CC-1065 Analogs and Their Conjugates PCNA, TOP1, TOP2B CYP2D6 2135/4885NOS3 4052/4885NOS1 3814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.